United States Drug Enforcement Administration

WASHINGTON - This week the heads of the national drug-control agencies for the United States and the People’s Republic of China, Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and Director (DG) Hu Minglang from the Narcotics Control (NCB) of the Ministry of Public Security, met at DEA Headquarters in Arlington...

PHILADELPHIA - Drug Enforcement (DEA) Special Agent in Charge Gary Tuggle, along with Federal Bureau of (FBI) Special Agent in Charge Michael Harpster and U.S. Attorney Zane David Memeger of the Eastern District of Pennsylvania, announced today that Chasing the Dragon: The Life of an Opiate Addict, a documentary about...

WASHINGTON - DEA has issued a public warning to the public and law enforcement nationwide about the health and safety risks of carfentanil. Carfentanil is a synthetic opioid that is 10,000 times more potent than morphine and 100 times more potent than fentanyl, which itself is 50 times more potent...

WASHINGTON - The Drug Enforcement (DEA) today announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety. Mitragynine and 7-hydroxymitragynine are found in kratom, which is a tropical tree indigenous...

PHILADELPHIA - Special Agent in Charge Gary Tuggle of the Drug Enforcement Administration’(DEA) Philadelphia Division announced today that the DEA will host a Pharmacy Diversion Awareness (PDAC) in Cumberland County, Pennsylvania as part of the DEA’s mission to address prescription opioid and heroin abuse. The diversion of pharmaceutical controlled substances...

WASHINGTON - The Drug Enforcement (DEA) announced several marijuana- related actions, including actions regarding scientific research and scheduling of marijuana, as well as principles on the cultivation of industrial hemp under the Agricultural Act of 2014. DEA Publishes Responses to Two Pending Petitions to Reschedule Marijuana - DEA has denied...

WASHINGTON - Hundreds of thousands of counterfeit prescription pills, many containing deadly amounts of fentanyl and fentanyl-related compounds, have made their way into the U.S. drug market, according to a DEA intelligence report released today. Law enforcement nationwide report higher fentanyl availability, seizures, and known overdose deaths than at any...

PHILADELPHIA - Gary Tuggle, Special Agent in Charge of the Drug Enforcement Administration’(DEA) Philadelphia Division, announced today that 3,383 drug-related overdose deaths were reported across Pennsylvania in 2015; an increase of 23.4% from the total number of overdose deaths reported in 2014. The DEA released its Analysis of Drug Related...

PHILADELPHIA - Gary Tuggle, Special Agent in Charge of the Drug Enforcement Administration’(DEA) Philadelphia Division, announced today that the DEA will release its Analysis of Drug Related Overdose Deaths in Pennsylvania, 2015 report. As the prescription opioid and heroin epidemic continues to plague the Commonwealth, a significant increase in overdose...

WASHINGTON - The United States Drug Enforcement (DEA) released the 2016 National Heroin Threat Assessment Summary - (NHTA) today. The report outlines the expanding public health crisis afflicting America due to the use and abuse of heroin and other opioid drugs. Some key facts: The number of people reporting current...